skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Advanced Glycation End-Products affect transcription factors regulating insulin gene expression

Journal Article · · Biochemical and Biophysical Research Communications
; ;  [1]
  1. Department of Internal Medicine and Medical Specialties, Viale Benedetto XV 6, 16132 Genova (Italy)

Advanced Glycation End-Products (AGEs) are generated by the covalent interaction of reducing sugars with proteins, lipids or nucleic acids. AGEs are implicated in diabetic complications and pancreatic {beta}-cell dysfunction. We previously demonstrated that exposure of the pancreatic islet cell line HIT-T15 to high concentrations of AGEs leads to a significant decrease of insulin secretion and content. Insulin gene transcription is positively regulated by the beta cell specific transcription factor PDX-1 (Pancreatic and Duodenal Homeobox-1). On the contrary, the forkhead transcription factor FoxO1 inhibits PDX-1 gene transcription. Activity of FoxO1 is regulated by post-translational modifications: phosphorylation deactivates FoxO1, and acetylation prevents FoxO1 ubiquitination. In this work we investigated whether AGEs affect expression and subcellular localization of PDX-1 and FoxO1. HIT-T15 cells were cultured for 5 days in presence of AGEs. Cells were then lysed and processed for subcellular fractionation. We determined intracellular insulin content, then we assessed the expression and subcellular localization of PDX-1, FoxO1, phosphoFoxO1 and acetylFoxO1. As expected intracellular insulin content was lower in HIT-T15 cells cultured with AGEs. The results showed that AGEs decreased expression and nuclear localization of PDX-1, reduced phosphorylation of FoxO1, and increased expression and acetylation of FoxO1. These results suggest that AGEs decrease insulin content unbalancing transcription factors regulating insulin gene expression.

OSTI ID:
22202495
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 395, Issue 1; Other Information: Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15
Journal Article · Fri Jul 30 00:00:00 EDT 2010 · Biochemical and Biophysical Research Communications · OSTI ID:22202495

FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells
Journal Article · Mon Jan 15 00:00:00 EST 2018 · Experimental Cell Research · OSTI ID:22202495

The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver
Journal Article · Fri Jan 07 00:00:00 EST 2011 · Biochemical and Biophysical Research Communications · OSTI ID:22202495